US Patent 11286265 Macrocyclic compounds for treating disease
Patent 11286265 was granted and assigned to Turning Point Therapeutics on March, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Dayong Zhai0
Evan W. Rogers0
Han Zhang0
Jane Ung0
Jeffrey Whitten0
Jingrong J. Cui0
Wei Deng0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 24 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112862650
Date of Patent
March 29, 2022
0Patent Application Number
168669830
Date Filed
May 5, 2020
0Official Website
Patent Citations
Patent Primary Examiner
CPC Code
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Golden AI
Infobox
Patent Citations
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Mar, 2022
Golden AI
Edits made to:
Infobox (+16 properties)
Article (+171 characters)
US Patent 11286265 Macrocyclic compounds for treating disease
Article
The present disclosure relates to certain macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat disease, such as cancer.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11286265
Date of patent
March 29, 2022
Patent application number
16866983
Date Filed
May 5, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11286265 Macrocyclic compounds for treating disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
